Fixed-Dose Combination Efavirenz/Tenofovir/FTC for South Africa
After a considerable wait (and considerable campaigning), in 2012, the South African Minister of Health, announced the award of a new antiretroviral tender -- worth R5.9 billion (£406,226,800).
For the first time since the ART program began, the tender includes a triple fixed-dose combination (FDC). The FDC is efavirenz/tenofovir/FTC for first line treatment and it is anticipated that over 90% of new patients will be eligible to initiate this FDC, including pregnant women.
The Southern African Clinicians Society advice document. Fixed-dose combination for adults accessing antiretroviral therapyView Full Article
Visit HIV i-Base's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)